---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-009335"
form_type: "8-K"
ticker: "SRXH"
cik: "0001471727"
company_name: "SRx Health Solutions, Inc."
filed_at: "2023-03-28T23:59:59+00:00"
generated_at: "2026-06-17T12:37:12.713157+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Better Choice FY2022 net sales $54.7M (+19% YoY) but net loss $39.3M; cash drops sharply

## Summary
- FY2022 net sales $54.7M (+19% YoY); Q4 net sales $9.3M (-15.6% YoY).
- Full year net loss $39.3M vs. net income $3.4M in FY2021; includes $18.6M goodwill impairment.
- Adjusted EBITDA loss widened to $(11.8)M from $(7.1)M in prior year.
- Cash and equivalents fell to $3.2M from $21.7M at year-end 2021; cash burn remains a key concern.
- International (+48%) and Brick & Mortar (+72%) drove growth; E-commerce (-3%) and DTC (-30%) declined.

## SEC filing metadata
- accession: 0001628280-23-009335
- form_type: 8-K
- ticker: SRXH
- cik: 0001471727
- company_name: SRx Health Solutions, Inc.
- filed_at: 2023-03-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1471727/000162828023009335/0001628280-23-009335-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1471727/000162828023009335/bttr-20230328.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-009335
- JSON: https://secwatch.observer/filing/0001628280-23-009335.json
- Plain text: https://secwatch.observer/filing/0001628280-23-009335.txt

## Key facts
- Earnings Releases
  SRx Health Solutions, Inc. reported the fourth quarter ended December 31, 2022 results: revenue $9.3 million, net income $24.4 million.
  - Period: the fourth quarter ended December 31, 2022
  - Revenue: $9.3 million
  - Net income: $24.4 million
  - Result: reported results
  source text: results for the fourth quarter and year ended December 31, 2022. Lionel F. Conacher, Interim CEO of Better Choice, stated, “During the fourth quarter, net sales were sales were $9.3 million resulting in full year 2022 net sales of $54.7 million, a 19% increase versus the prior year. Our International channel delivered year-over-year net sales growth of 48% and Brick
  evidence_url: https://www.sec.gov/Archives/edgar/data/1471727/000162828023009335/0001628280-23-009335-index.htm
- Earnings Releases
  SRx Health Solutions, Inc. reported the year ended December 31, 2022 results: revenue $54.7 million, net income $(39.3) million.
  - Period: the year ended December 31, 2022
  - Revenue: $54.7 million
  - Net income: $(39.3) million
  - Result: reported results
  source text: and Current Reports on Form 8-K. --- EX-99.1 (EX-99.1) --- Better Choice Company Reports Fourth Quarter and Full Year 2022 Financial Results Year-to-Date Net Sales Totaled $54.7 million, an Increase of 19% Year-over-Year Year-to-Date Gross Margin of 28%, or 31% Excluding the Impact of Inventory Rationalization NEW YORK, NY, March 28, 2023 -- Better Choice
  evidence_url: https://www.sec.gov/Archives/edgar/data/1471727/000162828023009335/0001628280-23-009335-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.